1. Home
  2. NBHC vs HROW Comparison

NBHC vs HROW Comparison

Compare NBHC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$37.95

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$49.68

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBHC
HROW
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
NBHC
HROW
Price
$37.95
$49.68
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$44.33
$68.86
AVG Volume (30 Days)
313.4K
550.3K
Earning Date
01-21-2026
11-10-2025
Dividend Yield
3.27%
N/A
EPS Growth
N/A
N/A
EPS
3.15
N/A
Revenue
$405,867,000.00
$250,042,000.00
Revenue This Year
$8.48
$38.96
Revenue Next Year
$28.10
$43.38
P/E Ratio
$12.03
N/A
Revenue Growth
1.03
47.83
52 Week Low
$32.83
$20.85
52 Week High
$44.93
$51.53

Technical Indicators

Market Signals
Indicator
NBHC
HROW
Relative Strength Index (RSI) 40.40 60.49
Support Level $39.35 $44.19
Resistance Level $40.68 $51.53
Average True Range (ATR) 0.61 2.32
MACD -0.29 -0.04
Stochastic Oscillator 8.36 71.25

Price Performance

Historical Comparison
NBHC
HROW

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: